Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica B Long

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Journal of the National Cancer Institute|August 13, 2014
ResponseSounok Sen, Shi-Yi Wang, Pamela R Soulos, et al.
Medical Care|May 17, 2019
Measuring Exposure to Incarceration Using the Electronic Health RecordEmily A Wang, Jessica B Long, Kathleen A McGinnis, et al.
JAMA Network Open|April 30, 2024
Area Vulnerability and Disparities in Therapy for Patients With Metastatic Renal Cell CarcinomaSyed N Rahman, Jessica B Long, Sarah J Westvold, et al.
Urology Practice|August 28, 2024
Associations Between Prostate Magnetic Resonance Imaging, Genomic Testing, and Treatment for Localized Prostate CancerVinaik M Sundaresan, Rong Wang, Jessica B Long, et al.
JNCI Cancer Spectrum|August 12, 2024
Cost trends of metastatic renal cell carcinoma therapy: the impact of oral anticancer agents and immunotherapyRebecca Forman, Jessica B Long, Sarah J Westvold, et al.
JAMA Network Open|October 24, 2025
Cost-Effectiveness and Evidence Gaps Surrounding PSMA-PET for Recurrent Prostate Cancer EvaluationNatalia Kunst, Jessica B Long, Preston C Sprenkle, et al.
JAMA Oncology|April 17, 2025
Adoption of Broad Genomic Profiling in Patients With CancerXiao Wang, John Rothen, Sida Huang, et al.
JNCI Cancer Spectrum|January 7, 2026
Risk of late recurrence of colorectal and breast cancer among older long-term cancer survivorsFaiza Yasin, Sarah J Westvold, Jessica B Long, et al.
JAMA Network Open|October 23, 2024
Long-Term Outcomes of Prostate-Specific Membrane Antigen-PET Imaging of Recurrent Prostate CancerNatalia Kunst, Jessica B Long, Sarah Westvold, et al.
British Journal of Haematology|September 22, 2016
Comparative clinical effectiveness of azacitidine versus decitabine in older patients with myelodysplastic syndromesAmer M Zeidan, Amy J Davidoff, Jessica B Long, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Journal of the National Cancer Institute|August 13, 2014
ResponseSounok Sen, Shi-Yi Wang, Pamela R Soulos, et al.
Medical Care|May 17, 2019
Measuring Exposure to Incarceration Using the Electronic Health RecordEmily A Wang, Jessica B Long, Kathleen A McGinnis, et al.
JAMA Network Open|April 30, 2024
Area Vulnerability and Disparities in Therapy for Patients With Metastatic Renal Cell CarcinomaSyed N Rahman, Jessica B Long, Sarah J Westvold, et al.
Urology Practice|August 28, 2024
Associations Between Prostate Magnetic Resonance Imaging, Genomic Testing, and Treatment for Localized Prostate CancerVinaik M Sundaresan, Rong Wang, Jessica B Long, et al.
JNCI Cancer Spectrum|August 12, 2024
Cost trends of metastatic renal cell carcinoma therapy: the impact of oral anticancer agents and immunotherapyRebecca Forman, Jessica B Long, Sarah J Westvold, et al.
JAMA Network Open|October 24, 2025
Cost-Effectiveness and Evidence Gaps Surrounding PSMA-PET for Recurrent Prostate Cancer EvaluationNatalia Kunst, Jessica B Long, Preston C Sprenkle, et al.
JAMA Oncology|April 17, 2025
Adoption of Broad Genomic Profiling in Patients With CancerXiao Wang, John Rothen, Sida Huang, et al.
JNCI Cancer Spectrum|January 7, 2026
Risk of late recurrence of colorectal and breast cancer among older long-term cancer survivorsFaiza Yasin, Sarah J Westvold, Jessica B Long, et al.
JAMA Network Open|October 23, 2024
Long-Term Outcomes of Prostate-Specific Membrane Antigen-PET Imaging of Recurrent Prostate CancerNatalia Kunst, Jessica B Long, Sarah Westvold, et al.
British Journal of Haematology|September 22, 2016
Comparative clinical effectiveness of azacitidine versus decitabine in older patients with myelodysplastic syndromesAmer M Zeidan, Amy J Davidoff, Jessica B Long, et al.
Pageof 7